Metropolitan Life Insurance CO Adicet Bio, Inc. Transaction History

Metropolitan Life Insurance CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$5.52 - $9.23 $4,333 - $7,245	-785 Reduced 37.31%	1,319 $7,000
Q4 2022 Jun 14, 2023	BUY	$7.72 - $21.27 $6,060 - $16,696	785 Added 59.51%	2,104 $18.8 Million
Q4 2022 Mar 30, 2023	BUY	$7.72 - $21.27 $4,485 - $12,357	581 Added 38.15%	2,104 $18,000
Q4 2022 Feb 15, 2023	BUY	$7.72 - $21.27 $4,485 - $12,357	581 Added 38.15%	2,104 $18,000
Q3 2022 Jun 14, 2023	BUY	$13.43 - $18.74 $2,739 - $3,822	204 Added 15.47%	1,523 $21.7 Million
Q2 2022 Jun 20, 2023	BUY	$10.26 - $20.81 $2,093 - $4,245	204 Added 15.47%	1,523 $22,000
Q1 2022 Jun 20, 2023	BUY	$11.53 - $19.97 $2,352 - $4,073	204 Added 15.47%	1,523 $30,000
Q1 2022 Mar 30, 2023	SELL	$11.53 - $19.97 $52,542 - $91,003	-4,557 Reduced 74.95%	1,523 $30,000
Q1 2022 May 12, 2022	SELL	$11.53 - $19.97 $52,542 - $91,003	-4,557 Reduced 74.95%	1,523 $30,000
Q4 2021 Jun 21, 2023	BUY	$7.37 - $17.49 $35,088 - $83,269	4,761 Added 360.96%	6,080 $106,000
Q4 2021 Mar 30, 2023	BUY	$7.37 - $17.49 $29,303 - $69,540	3,976 Added 188.97%	6,080 $106,000
Q4 2021 Feb 15, 2022	BUY	$7.37 - $17.49 $44,809 - $106,339	6,080 New	6,080 $106,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.